Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clinical Chemistry, 60, 631–643. THC DUID Data from Colorado from Jan 2011 to Feb 2014

Psychomotor performance, subjective and physiological effects and whole Blood '9 -Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis

Schwope, D.M.
Bosker, W.M.
Ramaekers, J.G.
Gorelick, D.A.
Huestis, M.A.

July 2012

Delta(9)-tetrahydrocannabinol (THC) is the illicit drug most frequently observed in accident and dri...

Psychomotor Performance, Subjective and Physiological Effects and Whole Blood D9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis

David M. Schwope
Wendy M. Bosker
Johannes G. Ramaekers
David A. Gorelick
Marilyn A. Huestis

September 2016

D9-tetrahydrocannabinol (THC) is the illicit drug most frequently observed in accident and driving u...

Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility?

Hädener, M.
Martin Fabritius, M.
König, S.
Giroud, C.
Weinmann, W.

October 2016

Heavy cannabis consumption is considered incompatible with safe driving. In Swiss traffic policy, dr...

Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clinical Chemistry, 60, 631–643. THC DUID Data from Colorado from Jan 2011 to Feb 2014

Nathalie A. Desrosiers
Sarah K. Himes
Karl B. Scheidweiler
Marta Concheiro-guisan
David A. Gorelick
Marilyn A. Huestis

January 2014

THC (THCCOOH) have been reported in blood from frequent cannabis smokers for an extended time during...

Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance

Karschner, E.L.
Swortwood, M.J.
Hirvonen, J.
Goodwin, R.S.
Bosker, W.M.
Ramaekers, J.G.
Huestis, M.A.

July 2016

Cannabis smoking increases motor vehicle accident risk. Empirically defined cannabinoid detection wi...

Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint

Toennes, S.W.
Ramaekers, J.G.
Theunissen, E.L.
Moeller, M.R.
Kauert, G.F.

January 2008

Cannabinoid pharmacokinetics in occasional users is well studied, but the interpretation of data fro...

THCCOOH concentrations in whole blood: are they useful in discriminating occasional from heavy smokers?

Fabritius, M.
Favrat, B.
Chtioui, H.
Battistella, G.
Annoni, J.M.
Appenzeller, M.
Dao, K.
Fornari, E.
Lauer, E.
Mall, J.F.
Maeder, P.
Mangin, P.
Staub, C.
Giroud, C.

October 2013

Some forensic and clinical circumstances require knowledge of the frequency of drug use. Care of the...

Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette

Marsot, Amélie
Audebert, Christine
Attolini, Laurence
Lacarelle, Bruno
Micallef, Joelle
Blin, Olivier

August 2016

International audiencePurpose. A randomized cross-over, double blind placebo controlled study of smo...

Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint

Fabritius, Marie
Chtioui, Haithem
Battistella, Giovanni
Annoni, Jean-Marie
Dao, Kim
Favrat, Bernard
Fornari, Eleonora
Lauer, Estelle
Maeder, Philippe
Giroud, Christian

June 2018

A cross-over controlled administration study of smoked cannabis was carried out on occasional and he...

Δ9-tetrahydrocannabinol (THC) is present in the body between smoking sessions in occasional non-daily cannabis users

Mørland, Jørg
Bramness, Jørgen Gustav

January 2020

Background: THC can be measured in blood up to a month after last intake in heavy cannabis users. Th...

THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis"

Pacifici, R.
Pichini, S.
Pellegrini, M.
Rotolo, M. C.
Giorgetti, R.
Tagliabracci, A.
Busardò, F. P.
Huestis, M. A.

January 2019

"Light cannabis" is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentratio...

Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.

Fabritius, M.
Chtioui, H.
Battistella, G.
Annoni, J.M.
Dao, K.
Favrat, B.
Fornari, E.
Lauer, E.
Maeder, P.
Giroud, C.

January 2013

A cross-over controlled administration study of smoked cannabis was carried out on occasional and he...

Do Δ9-Tetrahydrocannabinol Concentrations Indicate Recent Use in Chronic Cannabis Users?

Erin L. Karschner
Eugene W. Schwilke
Ross H. Lowe
Ph. D
W. David
Harrison G. Pope
Ph. D
Ronald Herning
Ph. D
Jean Lud Cadet
Marilyn A. Huestis
Ph. D

October 2015

AIMS—To quantify blood Δ9-tetrahydrocannabinol (THC) concentrations in chronic cannabis users over s...

Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use

Pichini S.
Mannocchi G.
Berretta P.
Zaami S.
Pirani F.
Pacifici R.
Busardo F. P.

January 2020

BACKGROUND: Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) time courses in serum and physiologi...

Psychomotor performance, subjective and physiological effects and whole Blood '9 -Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis

Schwope, D.M.
Bosker, W.M.
Ramaekers, J.G.
Gorelick, D.A.
Huestis, M.A.

July 2012

Delta(9)-tetrahydrocannabinol (THC) is the illicit drug most frequently observed in accident and dri...

Psychomotor Performance, Subjective and Physiological Effects and Whole Blood D9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis

David M. Schwope
Wendy M. Bosker
Johannes G. Ramaekers
David A. Gorelick
Marilyn A. Huestis

September 2016

D9-tetrahydrocannabinol (THC) is the illicit drug most frequently observed in accident and driving u...

Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility?

Hädener, M.
Martin Fabritius, M.
König, S.
Giroud, C.
Weinmann, W.

October 2016

Heavy cannabis consumption is considered incompatible with safe driving. In Swiss traffic policy, dr...

Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clinical Chemistry, 60, 631–643. THC DUID Data from Colorado from Jan 2011 to Feb 2014

Nathalie A. Desrosiers
Sarah K. Himes
Karl B. Scheidweiler
Marta Concheiro-guisan
David A. Gorelick
Marilyn A. Huestis

January 2014

THC (THCCOOH) have been reported in blood from frequent cannabis smokers for an extended time during...

Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance

Karschner, E.L.
Swortwood, M.J.
Hirvonen, J.
Goodwin, R.S.
Bosker, W.M.
Ramaekers, J.G.
Huestis, M.A.

July 2016

Cannabis smoking increases motor vehicle accident risk. Empirically defined cannabinoid detection wi...

Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint

Toennes, S.W.
Ramaekers, J.G.
Theunissen, E.L.
Moeller, M.R.
Kauert, G.F.

January 2008

Cannabinoid pharmacokinetics in occasional users is well studied, but the interpretation of data fro...

THCCOOH concentrations in whole blood: are they useful in discriminating occasional from heavy smokers?

Fabritius, M.
Favrat, B.
Chtioui, H.
Battistella, G.
Annoni, J.M.
Appenzeller, M.
Dao, K.
Fornari, E.
Lauer, E.
Mall, J.F.
Maeder, P.
Mangin, P.
Staub, C.
Giroud, C.

October 2013

Some forensic and clinical circumstances require knowledge of the frequency of drug use. Care of the...

Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette

Marsot, Amélie
Audebert, Christine
Attolini, Laurence
Lacarelle, Bruno
Micallef, Joelle
Blin, Olivier

August 2016

International audiencePurpose. A randomized cross-over, double blind placebo controlled study of smo...

Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint

Fabritius, Marie
Chtioui, Haithem
Battistella, Giovanni
Annoni, Jean-Marie
Dao, Kim
Favrat, Bernard
Fornari, Eleonora
Lauer, Estelle
Maeder, Philippe
Giroud, Christian

June 2018

A cross-over controlled administration study of smoked cannabis was carried out on occasional and he...

Δ9-tetrahydrocannabinol (THC) is present in the body between smoking sessions in occasional non-daily cannabis users

Mørland, Jørg
Bramness, Jørgen Gustav

January 2020

Background: THC can be measured in blood up to a month after last intake in heavy cannabis users. Th...

THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis"

Pacifici, R.
Pichini, S.
Pellegrini, M.
Rotolo, M. C.
Giorgetti, R.
Tagliabracci, A.
Busardò, F. P.
Huestis, M. A.

January 2019

"Light cannabis" is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentratio...

Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.

Fabritius, M.
Chtioui, H.
Battistella, G.
Annoni, J.M.
Dao, K.
Favrat, B.
Fornari, E.
Lauer, E.
Maeder, P.
Giroud, C.

January 2013

A cross-over controlled administration study of smoked cannabis was carried out on occasional and he...

Do Δ9-Tetrahydrocannabinol Concentrations Indicate Recent Use in Chronic Cannabis Users?

Erin L. Karschner
Eugene W. Schwilke
Ross H. Lowe
Ph. D
W. David
Harrison G. Pope
Ph. D
Ronald Herning
Ph. D
Jean Lud Cadet
Marilyn A. Huestis
Ph. D

October 2015

AIMS—To quantify blood Δ9-tetrahydrocannabinol (THC) concentrations in chronic cannabis users over s...

Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use

Pichini S.
Mannocchi G.
Berretta P.
Zaami S.
Pirani F.
Pacifici R.
Busardo F. P.

January 2020

BACKGROUND: Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) time courses in serum and physiologi...

Psychomotor performance, subjective and physiological effects and whole Blood '9 -Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis

Schwope, D.M.
Bosker, W.M.
Ramaekers, J.G.
Gorelick, D.A.
Huestis, M.A.

July 2012

Delta(9)-tetrahydrocannabinol (THC) is the illicit drug most frequently observed in accident and dri...

Psychomotor Performance, Subjective and Physiological Effects and Whole Blood D9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis

David M. Schwope
Wendy M. Bosker
Johannes G. Ramaekers
David A. Gorelick
Marilyn A. Huestis

September 2016

D9-tetrahydrocannabinol (THC) is the illicit drug most frequently observed in accident and driving u...

Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility?

Hädener, M.
Martin Fabritius, M.
König, S.
Giroud, C.
Weinmann, W.

October 2016

Heavy cannabis consumption is considered incompatible with safe driving. In Swiss traffic policy, dr...

Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clinical Chemistry, 60, 631–643. THC DUID Data from Colorado from Jan 2011 to Feb 2014

Abstract

Extracted data

Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clinical Chemistry, 60, 631–643. THC DUID Data from Colorado from Jan 2011 to Feb 2014

Abstract

Extracted data

Related items

Related items